Rare diseases
Investigational molecules
Locations
Back to Italy2 209 clinical trials in Rome, Italy across 15 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Effects of Pitolisant Hydrochloride for Patients with Prader-Willi Syndrome
ItalyItalyStudy on Revumenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy
ItalyStudy of GD2-CAR T Cells, Cyclophosphamide, and Fludarabine for Children with High-Risk or Relapsed Neuroblastoma and Other GD2+ Tumors
ItalyStudy on Toripalimab and Tifcemalimab for Patients with Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy
ItalyStudy on Luspatercept for Treating Anemia in Patients with Myelodysplastic Syndromes (MDS) with del5q, Resistant to Prior Treatments and Needing Blood Transfusions
ItalyStudy of Zilovertamab Vedotin and Drug Combination for Untreated Diffuse Large B-Cell Lymphoma Patients
ItalyStudy of Pozelimab and Cemdisiran for Adults with Geographic Atrophy from Age-Related Macular Degeneration
ItalyStudy Comparing Olaparib and Chemotherapy for Patients with Recurrent Ovarian Cancer After Surgery
ItalyStudy of EG-70 for Patients with Non-Muscle Invasive Bladder Cancer Unresponsive to BCG or High-Risk Patients New to BCG or with Incomplete BCG Treatment
ItalyItalyStudy Comparing the Safety and Effectiveness of Mexiletine PR and Mexiletine IR for Adults with Non-Dystrophic Myotonias
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on Idiopathic Pulmonary Fibrosis and COPD, evaluating new therapeutic approaches for improving lung function and reducing disease progression.
Advanced research includes novel antibody treatments and preventive measures for respiratory infections.
Innovative trials targeting metastatic colorectal cancer, gastric cancer, and acute myeloid leukemia, exploring new treatment combinations and targeted therapies.
Studies focus on improving response rates and survival outcomes in various cancer types.
Research into Parkinson's disease and acute ischemic stroke, investigating novel therapeutic approaches and neuroprotective strategies.
Studies aim to improve neurological outcomes and patient quality of life.
Clinical trials examining Immune Thrombocytopenia and Hidradenitis Suppurativa, testing new therapeutic agents for immune-mediated conditions.
Research focuses on improving treatment outcomes in challenging immune disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
